PMC:7405836 / 106280-106596 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T952","span":{"begin":280,"end":288},"obj":"Disease"},{"id":"T953","span":{"begin":280,"end":284},"obj":"Disease"},{"id":"T954","span":{"begin":291,"end":300},"obj":"Disease"}],"attributes":[{"id":"A952","pred":"mondo_id","subj":"T952","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A953","pred":"mondo_id","subj":"T953","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A954","pred":"mondo_id","subj":"T954","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"The in vitro antiviral potential of FAD-approved drugs, viz., ribavirin, penciclovir, nitazoxanide, nafamostat, and chloroquine, tested in comparison to remdesivir and favipiravir (broad-spectrum antiviral drugs) revealed remdesivir and chloroquine to be highly effective against SARS-CoV-2 infection in vitro (194)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T39","span":{"begin":129,"end":135},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"The in vitro antiviral potential of FAD-approved drugs, viz., ribavirin, penciclovir, nitazoxanide, nafamostat, and chloroquine, tested in comparison to remdesivir and favipiravir (broad-spectrum antiviral drugs) revealed remdesivir and chloroquine to be highly effective against SARS-CoV-2 infection in vitro (194)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T20398","span":{"begin":13,"end":22},"obj":"Chemical"},{"id":"T10424","span":{"begin":36,"end":39},"obj":"Chemical"},{"id":"T63494","span":{"begin":49,"end":54},"obj":"Chemical"},{"id":"T82009","span":{"begin":62,"end":71},"obj":"Chemical"},{"id":"T83127","span":{"begin":73,"end":84},"obj":"Chemical"},{"id":"T31981","span":{"begin":100,"end":110},"obj":"Chemical"},{"id":"T94988","span":{"begin":116,"end":127},"obj":"Chemical"},{"id":"T94700","span":{"begin":153,"end":163},"obj":"Chemical"},{"id":"T50085","span":{"begin":168,"end":179},"obj":"Chemical"},{"id":"T29816","span":{"begin":196,"end":211},"obj":"Chemical"},{"id":"T31421","span":{"begin":196,"end":205},"obj":"Chemical"},{"id":"T50124","span":{"begin":206,"end":211},"obj":"Chemical"},{"id":"T22947","span":{"begin":222,"end":232},"obj":"Chemical"},{"id":"T78915","span":{"begin":237,"end":248},"obj":"Chemical"}],"attributes":[{"id":"A84527","pred":"chebi_id","subj":"T20398","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A29046","pred":"chebi_id","subj":"T10424","obj":"http://purl.obolibrary.org/obo/CHEBI_16238"},{"id":"A95690","pred":"chebi_id","subj":"T10424","obj":"http://purl.obolibrary.org/obo/CHEBI_57692"},{"id":"A72207","pred":"chebi_id","subj":"T10424","obj":"http://purl.obolibrary.org/obo/CHEBI_73627"},{"id":"A3170","pred":"chebi_id","subj":"T63494","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A30080","pred":"chebi_id","subj":"T82009","obj":"http://purl.obolibrary.org/obo/CHEBI_63580"},{"id":"A7643","pred":"chebi_id","subj":"T83127","obj":"http://purl.obolibrary.org/obo/CHEBI_7956"},{"id":"A77107","pred":"chebi_id","subj":"T31981","obj":"http://purl.obolibrary.org/obo/CHEBI_135466"},{"id":"A67332","pred":"chebi_id","subj":"T94988","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A71772","pred":"chebi_id","subj":"T94700","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"},{"id":"A45716","pred":"chebi_id","subj":"T50085","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"},{"id":"A81207","pred":"chebi_id","subj":"T29816","obj":"http://purl.obolibrary.org/obo/CHEBI_36044"},{"id":"A26169","pred":"chebi_id","subj":"T31421","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A40546","pred":"chebi_id","subj":"T50124","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A91088","pred":"chebi_id","subj":"T22947","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"},{"id":"A13237","pred":"chebi_id","subj":"T78915","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"The in vitro antiviral potential of FAD-approved drugs, viz., ribavirin, penciclovir, nitazoxanide, nafamostat, and chloroquine, tested in comparison to remdesivir and favipiravir (broad-spectrum antiviral drugs) revealed remdesivir and chloroquine to be highly effective against SARS-CoV-2 infection in vitro (194)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T728","span":{"begin":0,"end":316},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The in vitro antiviral potential of FAD-approved drugs, viz., ribavirin, penciclovir, nitazoxanide, nafamostat, and chloroquine, tested in comparison to remdesivir and favipiravir (broad-spectrum antiviral drugs) revealed remdesivir and chloroquine to be highly effective against SARS-CoV-2 infection in vitro (194)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2867","span":{"begin":36,"end":39},"obj":"Chemical"},{"id":"2868","span":{"begin":62,"end":71},"obj":"Chemical"},{"id":"2869","span":{"begin":73,"end":84},"obj":"Chemical"},{"id":"2870","span":{"begin":86,"end":98},"obj":"Chemical"},{"id":"2871","span":{"begin":100,"end":110},"obj":"Chemical"},{"id":"2872","span":{"begin":116,"end":127},"obj":"Chemical"},{"id":"2873","span":{"begin":153,"end":163},"obj":"Chemical"},{"id":"2874","span":{"begin":168,"end":179},"obj":"Chemical"},{"id":"2875","span":{"begin":222,"end":232},"obj":"Chemical"},{"id":"2876","span":{"begin":237,"end":248},"obj":"Chemical"},{"id":"2885","span":{"begin":280,"end":300},"obj":"Disease"}],"attributes":[{"id":"A2867","pred":"tao:has_database_id","subj":"2867","obj":"MESH:D005182"},{"id":"A2868","pred":"tao:has_database_id","subj":"2868","obj":"MESH:D012254"},{"id":"A2869","pred":"tao:has_database_id","subj":"2869","obj":"MESH:C053539"},{"id":"A2870","pred":"tao:has_database_id","subj":"2870","obj":"MESH:C041747"},{"id":"A2871","pred":"tao:has_database_id","subj":"2871","obj":"MESH:C032855"},{"id":"A2872","pred":"tao:has_database_id","subj":"2872","obj":"MESH:D002738"},{"id":"A2873","pred":"tao:has_database_id","subj":"2873","obj":"MESH:C000606551"},{"id":"A2874","pred":"tao:has_database_id","subj":"2874","obj":"MESH:C462182"},{"id":"A2875","pred":"tao:has_database_id","subj":"2875","obj":"MESH:C000606551"},{"id":"A2876","pred":"tao:has_database_id","subj":"2876","obj":"MESH:D002738"},{"id":"A2885","pred":"tao:has_database_id","subj":"2885","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The in vitro antiviral potential of FAD-approved drugs, viz., ribavirin, penciclovir, nitazoxanide, nafamostat, and chloroquine, tested in comparison to remdesivir and favipiravir (broad-spectrum antiviral drugs) revealed remdesivir and chloroquine to be highly effective against SARS-CoV-2 infection in vitro (194)."}